BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22322956)

  • 1. Treatment management of small renal masses in the 21st century: a paradigm shift.
    Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving practice patterns for the management of small renal masses in the USA.
    Yang G; Villalta JD; Meng MV; Whitson JM
    BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic disparities in the treatment of small renal masses.
    Becker A; Roghmann F; Trinh QD; Hansen J; Tian Z; Shariat SF; Noldus J; Perrotte P; Graefen M; Karakiewicz PI; Sun M
    BJU Int; 2013 Jun; 111(8):E274-82. PubMed ID: 23714645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
    Baillargeon-Gagné S; Jeldres C; Lughezzani G; Sun M; Isbarn H; Capitanio U; Shariat SF; Crépel M; Alasker A; Widmer H; Arjane P; Patard JJ; Perrotte P; Montorsi F; Graefen M; Karakiewicz PI
    BJU Int; 2010 Feb; 105(3):359-64. PubMed ID: 20089096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of partial nephrectomy in European tertiary care centers.
    Zini L; Patard JJ; Capitanio U; Mejean A; Villers A; de La Taille A; Ficarra V; Crepel M; Bertini R; Salomon L; Verhoest G; Perrotte P; Bensalah K; Arjane P; Biserte J; Montorsi F; Karakiewicz P
    Eur J Surg Oncol; 2009 Jun; 35(6):636-42. PubMed ID: 18775626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
    Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M; Bratslavsky G
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Under-grading of <4 cm renal masses on renal biopsy.
    Harris CR; Whitson JM; Meng MV
    BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L; Perrotte P; Capitanio U; Jeldres C; Shariat SF; Antebi E; Saad F; Patard JJ; Montorsi F; Karakiewicz PI
    Cancer; 2009 Apr; 115(7):1465-71. PubMed ID: 19195042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
    Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
    BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of locally advanced and metastatic disease in patients with small renal masses.
    Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
    BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Duclos A; Jolivet-Tremblay M; Arjane P; Péloquin F; Pharand D; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study.
    Vricella GJ; Finelli A; Alibhai SM; Ponsky LE; Abouassaly R
    BJU Int; 2013 Jun; 111(8):1294-300. PubMed ID: 23368715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.